Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Prawitz, Thibaud
13  Ergebnisse:
Personensuche X
?
1

Efficacy of Mobocertinib and Amivantamab in Patients With A..:

Ou, Sai-Hong Ignatius ; Prawitz, Thibaud ; Lin, Huamao M....
Clinical Lung Cancer.  25 (2024)  3 - p. e145-e152.e3 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Ponatinib vs. Imatinib as Frontline Treatment for Philadelp..:

Ribera, Josep-Maria ; Prawitz, Thibaud ; Freitag, Andreas...
Advances in Therapy.  40 (2023)  7 - p. 3087-3103 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Indirect comparison of mobocertinib and real-world therapie..:

Christopoulos, Petros ; Prawitz, Thibaud ; Hong, Jin-Liern...
Lung Cancer.  179 (2023)  - p. 107191 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Net clinical benefit of antiplatelet therapy was affected b..:

Tervonen, Tommi ; Prawitz, Thibaud ; Chua, Gin Nie..
Journal of Clinical Epidemiology.  144 (2022)  - p. 84-92 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Trea..:

Cordoba, Raul ; Prawitz, Thibaud ; Westley, Tracy...
Advances in Therapy.  39 (2022)  6 - p. 2668-2687 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Discrete Choice Experiment to Understand Patient Preference..:

Seo, Jaein ; Thomas, Caitlin ; Tervonen, Tommi...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
7

DREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. ..:

Prawitz, Thibaud ; Popat, Rakesh ; Suvannasankha, Attaya...
Advances in Therapy.  38 (2021)  11 - p. 5501-5518 , 2021
Link: https://doi.org/10.1007/..
 
?
8

How Assessment-Schedule Matching Limits Bias When Comparing..:

Kapetanakis, Venediktos ; Prawitz, Thibaud ; Schlichting, Michael...
Value in Health.  24 (2021)  8 - p. 1137-1144 , 2021
Link: https://doi.org/10.1016/..
 
?
9

MM-209: Assessing Efficacy via Indirect Comparison of Singl..:

Suvannasankha, Attaya ; Kapetanakis, Venediktos ; Prawitz, Thibaud...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S300-S301 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Personalized benefit‐risk assessments combining clinical tr..:

Pinto, Cathy Anne ; Tervonen, Tommi ; Marsh, Kevin...
Pharmacoepidemiology and Drug Safety.  28 (2019)  4 - p. 443-451 , 2019
Link: https://doi.org/10.1002/..
 
?
11

Assessment-Schedule Matching in Unanchored Indirect Treatme..:

Kapetanakis, Venediktos ; Prawitz, Thibaud ; Schlichting, Michael...
PharmacoEconomics.  37 (2019)  12 - p. 1537-1551 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Net clinical benefit of antiplatelet therapy was affected b..:

Tervonen, Tommi ; Prawitz, Thibaud ; Chua, Gin Nie..
https://research.rug.nl/en/publications/acc96686-f892-4f03-b66d-42488eeaba22.  , 2022
Link: https://hdl.handle.net/1..
 
?
13

Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Trea..:

Cordoba, Raul ; Prawitz, Thibaud ; Westley, Tracy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122850/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-13